Crossmark

Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acid

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2023.01.001

Published Print: 2023-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ding, Dawei

Ren, Pengwei

Guo, Guanya

Liu, Yansheng

Yang, Chunmei

Zheng, Linhua

Jia, Gui

Deng, Juan

Sun, Ruiqing

Wang, Xiufang

Zhou, Xinmin

Shang, Yulong

Han, Ying
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81820108005, 81900502, 82173241)

National Key Research and Development Program of China (2017YFA0105704)

Key Research and Development Projects of Shaanxi Province (2021ZDLSF02-07)
License Information

Text and Data Mining valid from 2023-11-01

stm-asf valid from 2023-11-01

stm-asf valid from 2023-11-01

stm-asf valid from 2023-11-01

stm-asf valid from 2023-11-01

stm-asf valid from 2023-11-01
More Information

This article is maintained by: Elsevier

Article Title: Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acid

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2023.01.001

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below